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competition and collaboration. 
Research elsewhere is simultaneously 
described as a threat and an 
opportunity. To make the most of the 
latter, “the sponsors will work with 
overseas partners through established 
long-term relationships and new 
partnerships to capitalise upon 
emerging opportunities and provide 
access to complementary expertise 
that will benefit UK science,” the 
report states.
Oxford’s Paul Fairchild comments: 
“Recent initiatives to foster 
collaboration between UK scientists 
and those in countries such as Israel 
and China with a strong background in 
regenerative medicine is likely to 
bring a new perspective to the field 
and stimulate promising new avenues 
of research. The availability of new 
funding streams for joint projects 
between laboratories is particularly 
welcome.”
Around the world
A look around the globe continues 
to show a very colourful tapestry 
of different cultural attitudes to 
stem cell research and thus to the 
options of regenerative medicine. For 
instance, researchers in Germany are 
still banned from producing human 
embryonic stem cells and can only 
use imported cell lines if they were 
produced before 1st May 2007. In 
the US, opinions are divided and 
regulations differ between states, 
while countries such as Israel and 
South Korea enthusiastically support 
stem cell research. 
The debate over ethical concerns 
raised especially by the Christian 
churches has recently been 
highlighted, when the Vatican’s 
scientific academy cancelled a 
conference on adult stem cells that 
was due to be held at the end of 
April. The organiser’s brief to focus 
on “responsible stem cell research”, 
i.e. to exclude research on embryonic 
stem cells, had already divided the 
research community, with some 
scientists accepting the invitation, 
while others called to boycott the 
event. 
On the other side of the debate, the 
fact that some of the invited speakers, 
including keynote speaker George 
Daley from the Children’s Hospital at 
Boston (Massachusetts), are famous 
for their work with embryonic stem 
cells, produced disquiet among 
the members of the Pontifical 
Academy for Life, which organised 
the event. While the academy cited 
organisational reasons for the 
cancellation, internal debate on the 
choice of speakers may conceivably 
have had something to do with it. 
Which would be ironic, because today, 
more than ever, regenerative medicine 
has a range of options beyond the use 
of embryonic stem cells. 
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web 
page at www.michaelgross.co.uk
Vatican views: The Catholic church is among the organisations with the strongest objections 
against the use of human embryonic stem cells for research into regenerative medicine. The 
photo shows the Vatican and St. Peter’s Basilica in Rome. (Photo: Wikimedia Commons.)
Q & AOttoline Leyser
Ottoline Leyser graduated with a 
BA in Genetics from the University 
of Cambridge in 1986. As an 
undergraduate, she was inspired by 
an interdepartmental developmental 
biology course, which highlighted for 
her the power of genetic approaches, 
and the extent to which plant 
developmental biology was lagging 
behind, at least in part through the 
lack of a really tractable genetic 
model system. Fortunately, it was 
exactly at this time that Arabidopsis 
began its exponential rise as a model 
for plant developmental genetics, 
and she stayed in the Cambridge 
Genetics Department to pursue a PhD 
on Arabidopsis shoot apical meristem 
mutants with Ian Furner. After a post-
doc in Bloomington, Indiana with 
Mark Estelle studying auxin mutants, 
eventfully punctuated by the births 
of her two children, and a brief spell 
back in Cambridge, she moved to 
the University of York. There, she 
established a research project on the 
hormonal control of shoot branching, 
which has been the focus of her 
research ever since. Last year she 
took up a new post as Professor of 
Plant Development and Associate 
Director of the Sainsbury Laboratory 
at the University of Cambridge. 
What turned you on to biology in 
the first place? I like to understand 
how things work, and, to my mind, 
living systems are really the most 
interesting to understand, because 
they were built by evolution. This 
makes their logic often non-intuitive 
and means that their organisation 
is inherently multi-scale, with the 
properties of the whole organism, 
or indeed whole ecosystems, both 
emerging from and in turn influencing 
the interactions of component 
parts at multiple successive 
lower-level scales. This is the 
reason I find genetics particularly 
appealing — because it affords us the 
extraordinary ability to link specific 
and informative macro-scale changes 
to single nucleotide DNA-level 
changes. These techniques powerfully 
link genotype to phenotype, but the 
challenge then is to work out the 
steps in between. 
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so, what is it? One of my favourite 
illustrations of the ability to 
understand micro-scale phenomena 
from macro-scale observations 
is the detailed prediction of the 
structure of the Holliday junction 
from the phenotypes of ordered 
ascospores (e.g. Stadler, Towe 
and Rossignol (1970). Genetics 
66:429–447). Deducing the existence 
of asymmetric heteroduplex DNA 
at points of recombination just by 
scoring spore colours is really a 
beautiful thing. 
Why development and why 
plants? The assembly of a complex 
multicellular organism through 
the successive divisions and 
decisions of single cells is for me 
an irresistible problem. In plants, 
this is happening in a way that is 
profoundly influenced by the external 
environment, such that a single plant 
genotype can occupy a huge area of 
phenotype space. It is this plasticity 
in development that I would really 
like to understand, and in this area 
plants are really the masters. On 
top of that, given the central role of 
plants in the agricultural systems and 
ecosystems on which we all depend, 
I think there is currently a serious 
underinvestment of both money and 
human ingenuity in plant biology. If 
we can’t work out how to make more 
plant with less input, sustainably, 
we are in big trouble. I can see why 
people are so obsessed with animal 
biology — we are animals and we 
would like to know about ourselves. 
But the very fact that plants are not 
animals, that they evolved under very 
different selective pressures and 
that they have solved the problems of systemic integration in different 
ways, for me makes them much more 
interesting. 
What is the best advice you’ve been 
given, and what advice would you 
offer someone wondering whether 
to start a career in biology? My 
PhD supervisor says I only ask for 
advice after I have already made up 
my mind, which is probably true. I 
suppose it is consistent with this 
attitude that the advice I most often 
give out is “don’t take advice”. I think 
it is important to work out what you 
want to do and why you want to do 
it. It is, of course, very helpful to get 
a good range of advice on the best 
way to go about it, and, importantly, 
on what options are available to keep 
moving in that direction if plan A 
doesn’t work. But unless you know 
what you want, advice is not much 
use, especially when so much of 
the advice people give out these 
days seems to be entirely negative. 
I think this is very unhelpful. Science 
is necessarily competitive, not in a 
stab-your-colleagues-in-the-back 
way, but because there are limited 
resources and lots of ideas about 
what to do with them. This situation 
leads to superstition — people will 
naturally invent reasons why plan A 
didn’t work that involve something 
other than bad luck, and/or someone 
else winning the competition that 
time. 
It is easy to build a story for 
yourself that you didn’t get the 
job/grant because you didn’t do 
your PhD with the right Nobel Prize 
winner, you stayed in your home 
country for your post-doc and your 
breakthrough paper wasn’t published 
in Current Biology, but, if you think 
of all the research career rules you 
have ever heard, you can always find 
plenty of super-successful people 
who have broken them all. One 
example particularly close to my 
heart is that every woman researcher 
is repeatedly told that it is virtually 
impossible to combine a career in 
science with having children, and 
if you are going to take the risk, 
then you should certainly wait until 
you have tenure. This is patently 
nonsense. To start with, men have 
being doing this for centuries, and, 
if you have a supportive partner, 
it is perfectly possible for women 
too — giving birth really does not 
take long when viewed over a career-level timescale. I am not saying it is 
easy, but it is perfectly possible. You 
would not get this impression from 
the advice given out all the time to 
women researchers, despite excellent 
evidence that it can be done (e.g. 
see Mothers in Science: 64 ways to 
have it all, available free at http://
royalsociety.org/about-us/equality/
activities/ (shameless plug for my 
own book)).
Do you have a ‘hero’ among plant 
biologists (dead or alive)? Pretty 
much everything I’ve said so far is 
beautifully illustrated by the life and 
work of Barbara McClintock. 
If you knew what you know earlier 
on, would you still pursue the same 
career/research path? Yes, I would 
definitely pursue the same career. It 
is a real privilege to do this work. I 
am enjoying all of it immensely. 
What has been your biggest 
mistake? I should have kept my 
maths going for longer. I am having 
to re-learn the language needed for 
intuition about dynamics and network 
properties. Fortunately, I have 
wonderfully patient collaborators to 
plug the gap. I have just moved my 
lab to the Sainsbury Laboratory at 
the University of Cambridge. This is 
a new research institute funded by 
the Gatsby Foundation where the 
aim is to integrate fully experimental 
and computational approaches to 
understand plant developmental 
biology. I am very excited about 
working in this kind of environment.
What is your favourite/least 
favourite conference? I like a mixture 
of conferences — the big impersonal 
ones to get an overview of things 
outside my area of focus, and the 
small, specific ones with less dense 
schedules to promote detailed 
discussion.
What do you think about the 
‘electronic revolution’ in publishing, 
journals and the peer review 
system? I am looking forward to the 
day when everyone just publishes 
in some kind of online repository 
with pre-publication peer review for 
quality and rigor, and then post-
publication commentary to help 
everyone navigate to find the papers 
of specific interest to them. We 
all spend far, far too much time at 
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Antiparasite 
behavior
Brian Gray, Anne C. Jacobs,  
Adrienne B. Mora, and Marlene Zuk
What is antiparasite behavior? 
Parasites are ubiquitous, and 
organisms have evolved a number 
of ways for dealing with parasitism. 
However, the traditional view of 
antiparasite defense is one steeped 
in host physiological responses, such 
as mounting an immune response. 
In contrast, antiparasite behavior 
is relatively understudied, despite 
being a particularly robust way for 
organisms to resist parasitism. 
Antiparasite behavior is used 
to evade, kill, or otherwise avoid 
parasites. It is analogous to anti-
predator behavior, but unlike those 
behaviors, antiparasite behavior 
includes a variety of post-infective 
behaviors — actions animals can 
take to rid themselves of parasites, or 
mitigate the effects of parasitism — 
which take place only after an animal 
is infested by a parasite, rather than 
behaviors aimed at avoiding infection 
in the first place.
Can you give me some examples? 
Many animals display antiparasite 
behavior. Cattle avoid areas that are 
potentially infected with parasites, 
such as areas littered with feces that 
may contain worm larvae, and several 
species of birds counter the activities 
of brood parasites by rejecting 
parasitic eggs or deserting nests 
containing such eggs. 
However, much of the available 
literature on antiparasite behavior 
is restricted to a small number of 
taxa. Such behavior has been best 
described in birds affected by brood 
parasites, and in mammals, especially 
primates and ungulates. Only recently 
have researchers turned their attention 
to describing similar behaviors in 
other taxa, and much remains to be 
discovered. For example, honeybees 
remove larvae infected with mites and 
bacteria from their hives to prevent 
the spread of the infection to the rest 
of the colony. European starlings line 
their nests with specific types of green 
Quick guide plant material to kill ectoparasites, a form of fumigation. Sticklebacks 
take advantage of the dilution effect 
by shoaling to reduce an individual’s 
likelihood of being infected with 
ectoparasites, and a species of 
North American field cricket grooms 
extensively when exposed to the 
larvae of a lethal parasitoid fly, 
dramatically reducing the risk of death 
associated with infestation. Expanding 
studies to include a broader range 
of taxa is likely to yield exciting new 
insights into antiparasite behavior. 
How is this different from 
antipredator behavior? Antiparasite 
behavior can be similar to the 
behaviors employed in avoiding 
predators — using camouflage, 
spending time in groups to take 
advantage of the dilution and selfish 
herd effects, and avoiding areas 
frequented by the predators/parasites. 
However, antiparasite behaviors 
may also differ substantially from 
antipredator behaviors; the two may 
even trade-off against one another, 
with particular behaviors that protect 
against predators increasing the 
likelihood of parasitism and vice 
versa. For example, when cattle 
congregate in groups, they often turn 
their heads in towards the center of 
the group. This helps protect their 
faces from biting flies, but reduces 
their ability to watch for predators.
Also, unlike predators, which kill 
their prey, many parasites depend on 
the continued survival of hosts. As 
such, hosts can utilize a number of 
post-infective behaviors, which may 
differ substantially from antipredator 
behaviors.
What do you mean by post-infective 
behavior? Post-infective behavior 
refers to anything an animal might 
do to reduce parasite load after 
being infected by a parasite. This 
might include grooming to remove 
attached ectoparasites, such as 
lice or ticks, ejecting parasitic eggs 
(in the case of brood parasitism), 
or moving to a warm place (for 
ectotherms) to generate behavioral 
fever and combat pathogens. In 
some cases, animals may self-
medicate with plants or other 
antiparasitic compounds, which 
may be particularly effective against 
endoparasites. These behaviors are 
used by hosts to either reduce the 
number of parasites or somehow present arguing with referees and 
editors to try to get our papers into 
places where we hope they will be 
read. Eventually, this shouldn’t be 
necessary. The problem is getting 
from here to there — it is not at all 
clear to me how and when this should 
happen most effectively.
What do you think are the biggest 
challenges to the scientific 
community in the short/medium/
long term? I think we need to get 
out more. Science has become 
ghettoised. The pressures of the 
grant-publication-grant cycle 
are keeping people in their labs, 
talking to a very narrow range of 
people. Science is increasingly 
a disconnected and segregated 
activity. This situation has a lot of 
very negative consequences. Among 
them, the public becomes suspicious 
of science and innovation, delaying or 
preventing the adoption of science-
driven solutions to societal problems; 
interesting synergies between 
unlikely partners are missed; and 
research careers look unattractive to 
the next generation. 
There has been a lot of complaint in 
the community about the UK Research 
Council Impact Agenda, and the 
requirement to explain ‘pathways to 
impact’ in grant applications. People 
think it is about making us predict how 
our research might be applied in the 
future and/or making us do research 
that is immediately applicable. I 
disagree with this interpretation. 
I think it is about highlighting the 
imperative that science and scientists 
engage with a much wider range of 
people than is currently usually the 
case. This includes wider engagement 
with academia; the public, private 
and charitable sectors; and a range 
of general audiences. The current 
isolationism is giving the impression 
that science is some kind of special 
activity accessible only to the 
chosen few who think they are 
infallible. Science is a very creative 
and inclusive human thing, with 
tremendous power to improve life for 
everyone. If we can’t reintegrate it 
with everything else, then its potential 
will be lost. So I think we should stop 
complaining and get out more. 
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